Condition 1: Acute coronary syndrom. Condition 2: Stress. Condition 3: Aromatherapy. Condition 4: Mean atrial pressure and Heart rate. Non-ST elevation (NSTEMI) myocardial infarction Acute stress reaction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definitive diagnosis of acute coronary syndrome by a specialist based on evidence based electrocardiogram and clinical signs and troponin index No respiratory disease such as asthma and COPD and allergies or allergies to plants Entering the emergency department without cardiac arrest Vigilance and Awareness of place, time and person No history of head trauma and seizure No history of confirmed mental illness No opium and alcohol addiction No history of PTSD in during the last six months No history of using other complementary therapies for at least one month before intervention No disruption of sense of smell Mean arterial blood pressure more than 90 and heart rate more than 60 Patients with chest pain severity of 3 and more based on visual analogue scale (VAS) Age over 35 and under 65 years
Exclusion criteria
Exclusion criteria: Patients Candidate for primary PCI Patient's unwillingness to continue participation Unstable hemodynamic (20% change compared to time of start intervention) Incidence of arrhythmias and allergic and respiratory problems during intervention Transfer patients from the emergency department to the intensive care unit in less than 3 hours Patient connection to mechanical ventilation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stress score in DASS-21 questionnaire. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: DASS-21 Stress Questionnaire.;Mean Atrial Pressure. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Heart rate. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Threat perception score. Timepoint: Before and the end of intervention. Method of measurement: Threat Perception Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| ??? ?? ??????pain. Timepoint: Before the intervention, 5 and 15 minutes after the intervention in two aromatherapy treatments. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Khoram-Abad University of Medical Sciences